
Zynex ZYXI
Quarterly report 2025-Q3
added 11-17-2025
Zynex Total Non Current Liabilities 2011-2026 | ZYXI
Annual Total Non Current Liabilities Zynex
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | 3.43 M | 531 K | 12 K | 148 K | 228 K | 324 K | 2.69 M | 1.79 M | 1.9 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 3.43 M | 12 K | 1.23 M |
Total Non Current Liabilities of other stocks in the Medical devices industry
| Issuer | Total Non Current Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Aethlon Medical
AEMD
|
42.5 K | $ 2.22 | 5.21 % | $ 3.47 M | ||
|
AdaptHealth Corp.
AHCO
|
424 M | $ 10.55 | 1.25 % | $ 1.43 B | ||
|
Allied Healthcare Products
AHPI
|
115 K | - | 3.58 % | $ 2.21 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
85.2 M | - | - | $ 1.77 B | ||
|
Cognyte Software Ltd.
CGNT
|
1.33 M | $ 8.37 | -0.18 % | $ 601 M | ||
|
Acutus Medical
AFIB
|
44 M | - | -26.83 % | $ 2.62 M | ||
|
Alphatec Holdings
ATEC
|
89.9 M | $ 12.96 | 2.82 % | $ 1.94 B | ||
|
Obalon Therapeutics, Inc.
OBLN
|
906 K | - | -5.86 % | $ 30.6 M | ||
|
Aziyo Biologics
AZYO
|
35.2 M | - | 1.37 % | $ 20.5 M | ||
|
EDAP TMS S.A.
EDAP
|
7.44 M | $ 4.07 | 2.73 % | $ 152 M | ||
|
Avinger
AVGR
|
12.7 M | - | -20.74 % | $ 369 K | ||
|
BIOLASE
BIOL
|
5.69 M | - | -13.19 % | $ 166 K | ||
|
Boston Scientific Corporation
BSX
|
11.8 B | $ 71.21 | 2.03 % | $ 105 B | ||
|
Establishment Labs Holdings
ESTA
|
53.7 M | $ 65.47 | 3.13 % | $ 1.94 B | ||
|
CONMED Corporation
CNMD
|
877 M | $ 37.07 | -0.91 % | $ 1.15 B | ||
|
Conformis
CFMS
|
29.2 M | - | - | $ 16.4 M | ||
|
Cytosorbents Corporation
CTSO
|
14 M | $ 0.69 | 6.15 % | $ 37.6 M | ||
|
Apollo Endosurgery
APEN
|
59 M | - | - | $ 475 M | ||
|
Cutera
CUTR
|
430 M | - | -10.19 % | $ 1.99 M | ||
|
CryoLife, Inc.
CRY
|
400 M | - | -4.14 % | $ 702 M | ||
|
Dynatronics Corporation
DYNT
|
10 M | - | 14.99 % | $ 929 K | ||
|
ClearPoint Neuro
CLPT
|
23.9 M | $ 11.2 | 1.54 % | $ 303 M | ||
|
Axonics Modulation Technologies
AXNX
|
24.8 M | - | - | $ 3.31 B | ||
|
Soliton, Inc.
SOLY
|
4.28 K | - | -1.42 % | $ 435 M | ||
|
IRIDEX Corporation
IRIX
|
2.33 M | $ 1.33 | - | $ 21.5 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
568 K | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
3.08 M | - | 0.03 % | $ 1.58 B | ||
|
Misonix, Inc.
MSON
|
39.9 M | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
8.24 M | - | - | $ 111 M | ||
|
FONAR Corporation
FONR
|
36.4 M | $ 18.43 | 0.05 % | $ 121 M | ||
|
Helius Medical Technologies
HSDT
|
252 K | $ 2.24 | 2.43 % | $ 1.36 M | ||
|
InMode Ltd.
INMD
|
12.5 M | $ 13.57 | 1.01 % | $ 877 M | ||
|
LivaNova PLC
LIVN
|
516 M | $ 62.78 | 2.2 % | $ 3.42 B | ||
|
Intersect ENT, Inc.
XENT
|
116 M | - | - | $ 955 M | ||
|
Abbott Laboratories
ABT
|
25.7 B | $ 111.63 | 1.53 % | $ 194 B | ||
|
MiMedx Group
MDXG
|
65.4 M | $ 4.39 | -0.34 % | $ 649 M | ||
|
Delcath Systems
DCTH
|
2.52 M | $ 9.87 | 0.61 % | $ 354 M | ||
|
Bio-Rad Laboratories
BIO
|
1.35 B | $ 269.13 | 3.02 % | $ 7.59 B | ||
|
Nano-X Imaging Ltd.
NNOX
|
6.91 M | $ 2.59 | - | $ 152 M | ||
|
Integra LifeSciences Holdings Corporation
IART
|
1.56 B | $ 9.17 | 1.78 % | $ 706 M | ||
|
AxoGen
AXGN
|
1.61 M | $ 33.1 | 0.79 % | $ 1.52 B | ||
|
Align Technology
ALGN
|
184 M | $ 178.63 | 5.42 % | $ 13.4 B | ||
|
Bruker Corporation
BRKR
|
1.28 B | $ 33.89 | 3.43 % | $ 5.05 K | ||
|
BioSig Technologies
BSGM
|
103 K | - | 37.08 % | $ 85.7 M | ||
|
Apyx Medical Corporation
APYX
|
1.1 M | $ 3.75 | 2.18 % | $ 154 M | ||
|
OrthoPediatrics Corp.
KIDS
|
116 M | $ 17.29 | 1.05 % | $ 406 M |